Find Academic Supervisors

Ryan M Hebert, MD, is an Assistant Professor of Neurosurgery at the Yale School of Medicine, affiliated with the Neurosurgery department. He specializes in neurovascular disorders, including open and endovascular treatments for intracranial aneurysms, arteriovenous malformations, carotid disease, and dural arteriovenous fistulas. He also focuses on interventions for ischemic and hemorrhagic strokes. His practice locations include Yale New Haven Hospital and Lawrence and Memorial Hospitals in Connecticut. Education & Training: Bachelor’s in Molecular, Cellular, and Developmental Biology from the University of Colorado – Boulder (Howard Hughes Undergraduate Research Grant recipient) MD from Yale School of Medicine (NIH-funded thesis on CCM3 in cerebral cavernous malformations) 7-year Neurosurgery Residency at Yale New Haven Hospital, including enfolded neuro-interventional training CAST-accredited fellowship in Endovascular Neurosurgery and Neurovascular Critical Care at Thomas Jefferson University Hospital (2016) Research Interests: Dr. Hebert’s work centers on emerging surgical and endovascular techniques for neurovascular disorders, risk stratification in carotid disease, vasospasm prediction/post-subarachnoid hemorrhage treatment, and outcomes of minimally invasive spine surgery. His studies often integrate clinical practice with translational research, emphasizing patient outcomes and procedural optimization. Key topics include flow diverters, cranial nerve palsies, hospital frailty risk scores, and immune mechanisms driving aneurysm rupture. Publications Trends: His recent articles emphasize clinical outcomes of endovascular procedures, stroke interventions, and immune mechanisms in aneurysm rupture. He frequently collaborates on meta-analyses and systematic reviews to evaluate treatment efficacy and complication rates, particularly involving cranial nerve recovery and thrombectomy volumes. Awards & Grants: He secured an NIH-funded thesis and a Howard Hughes Undergraduate research grant. No explicit scientific awards are listed, but his work has been recognized via peer-reviewed publications and contributions to clinical guidelines. Advising & Grants: While no students are listed, he collaborates with prominent researchers like Charles Matouk, Kevin Sheth, and Joseph Antonios on NIH-funded projects. His research addresses healthcare resource utilization and procedural volume impacts on mortality, indicating a focus on translational and clinical studies. Labs & Teams: Active in interdisciplinary teams at Yale School of Medicine, particularly in neurovascular critical care and endovascular surgery. Collaborates with the Stroke Center and Janeway Society for physician-scientist development.

• Neurovascular Surgery
• Cerebrovascular Disorders
• Stroke Intervention
• +3 more

Ahmed Hassoon is an Assistant Research Professor at the Johns Hopkins Bloomberg School of Public Health, with a primary appointment in the Department of Epidemiology and joint appointments in the Department of Neurology at the School of Medicine and the School of Engineering. He is affiliated with several key research centers, including the Welch Center for Prevention, Epidemiology and Clinical Research, the Center for Diagnostic Excellence, and the Center for Humanitarian Health. MPH, Johns Hopkins Bloomberg School of Public Health, 2014 MD, Baghdad College of Medicine, 2004 Dr. Hassoon’s research is centered on leveraging data science and artificial intelligence to improve healthcare quality and safety, particularly in diagnostic accuracy. His work spans applications in lung cancer, stroke, and emergency medicine, with a strong emphasis on reducing diagnostic errors using frameworks like symptom-disease pair analysis (SPADE). He is deeply engaged in developing AI models that reason across multiple clinical modalities to enhance patient outcomes. His recent publications highlight a strong trend in diagnostic safety, AI-driven interventions, and epidemiological analysis of misdiagnosis harms. Key themes include the validation of computable phenotypes, measurement of diagnostic error burden, and the impact of mental health on acute care diagnostics. Hubert Humphrey Fellowship Award, U.S. Department of State (2010) US President Appreciation Certificate, The White House (2011) Atlas Corps Award (2012) Sommer Scholarship Award (2013) State of Maryland Cigarette Restitution Fund Faculty and Translational Research Awards (2016–2017) Institute for Healthcare Improvement (IHI) Fellowship (2024) Dr. Hassoon is a recipient of the AHRQ K08 Career Development Award focused on improving cancer diagnostic safety at Johns Hopkins Hospital. He co-instructs graduate-level courses in data science and AI with Professor Brian Caffo, contributing to the training of the next generation of public health data scientists. He has not formally advised students listed in the provided texts. His collaborative research spans multiple institutions and has been widely disseminated through policy, news, and social media, indicating significant real-world impact. His work is deeply integrated with the Welch Center and the Center for Diagnostic Excellence, where he contributes to translational research initiatives aimed at improving clinical decision-making and patient safety through innovative data-driven approaches.

• Artificial Intelligence
• Multi-modal reasoning
• Diagnostic Safety
• +9 more

Devin Amin, MD, is an Associate Professor in the Department of Surgery at Southern Illinois University School of Medicine and serves as the Program Director for the Neurosurgery Residency Program. He is a board-certified neurosurgeon specializing in advanced surgical techniques for pituitary and skull base disorders. University of Pittsburgh, MD Carnegie Mellon University, PhD in Biomedical Engineering University of Pittsburgh, Residency in Neurological Surgery Dr. Amin's clinical expertise lies in endoscopic pituitary and skull base surgery , while his research focuses on Image Guided Surgery and minimally invasive approaches. His work bridges engineering innovation with clinical applications in neurosurgery. The articles related to Dr. Amin highlight advancements in skull base surgery , including hands-on training initiatives and groundbreaking transorbital procedures in central Illinois. These works emphasize trends in minimally invasive techniques , neurosurgical education , and interdisciplinary collaboration . Excellence in Medical Teaching Award (2012, 2013, 2014, 2016, 2017, 2022) As Program Director for Neurosurgery Residency, Dr. Amin oversees training programs and contributes to surgical education. His clinical practice involves cutting-edge procedures like transorbital skull base surgery, reflecting his commitment to advancing neurosurgical techniques.

• Neurosurgery
• Image Guided Surgery
• Minimally Invasive Surgery
• +3 more

Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.

• Stroke
• Cerebrovascular Disease
• Brain Aneurysms
• +3 more

Dr. Sameer A Ansari, MD, PhD is a Professor of Radiology (Interventional Neuroradiology), Neurological Surgery, and Neurology at Northwestern University's Feinberg School of Medicine. He holds appointments in multiple departments reflecting his interdisciplinary expertise in neurovascular interventions and stroke care. His educational background includes: MD from Jefferson Medical College, Thomas Jefferson University (2000) PhD from College of Graduate Studies, Thomas Jefferson University (2000) Radiology Residency at University of Illinois at Chicago (2005) Neuroradiology Fellowship at University of Michigan Health System (2006) Interventional Neuroradiology Fellowship at University of Michigan Health System (2008) Dr. Ansari is board certified in both Neuroradiology and Diagnostic Radiology by the American Board of Radiology. His primary research interests focus on endovascular treatment of neurovascular diseases, particularly advanced MRI techniques to optimize patient selection for acute ischemic stroke interventions and intracranial atherosclerotic disease treatments. He has published extensively on stroke thrombectomy outcomes, intracranial aneurysm management, and neurointerventional oncology. His recent publications (2025) demonstrate significant contributions across multiple domains including probabilistic modeling for stroke outcomes prediction, racial disparities in aneurysm treatment, novel approaches to medium vessel occlusion, and the emerging field of neurointerventional oncology. His work frequently leverages the NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) registry to generate real-world evidence. Dr. Ansari maintains active leadership roles in professional societies: Scientific Exhibits Committee-Interventional, ASNR (2010-Present) Session Moderator-Adult Brain: Vascular, Intracranial, ASNR (2010-Present) AHA/ASA Abstract Grading Subcommittee, International Stroke Meeting (2010-Present) Presentation Award Committee-Interventional, ASNR (2010-Present) His professional society memberships include the American Heart/Stroke Association, American Society of Neuroradiology, Society of Neurointerventional Surgery, American Roentgen Ray Society, American University Radiologists, American College of Radiology, and Radiological Society of North America. In 2024, he served on boards for the American Board of Radiology, American College of Radiology, American Heart Association, and multiple medical device companies including Boston Scientific, Medtronic, and MicroVention. Dr. Ansari's clinical work focuses on the endovascular treatment of neurovascular diseases, with particular expertise in acute stroke intervention and complex cerebrovascular disorders. His research bridges clinical practice with advanced imaging techniques to improve patient outcomes in neurointerventional procedures.

• Endovascular Treatment
• Neurovascular Diseases
• Advanced MRI Techniques
• +5 more

Dr. Kiran T. Thakur serves as the Herbert Irving Associate Professor of Neurology at Columbia University Irving Medical Center and practices as an inpatient neurologist at NewYork-Presbyterian/CUIMC. Her clinical expertise spans neuroinfectious diseases, neuroimmunology, emergency neurology, and global health, with active clinical and research engagements across eight countries in Africa, Southeast Asia, and the Caribbean. She holds leadership roles including Neurology Clerkship Director at Perdana University Graduate School of Medicine (Malaysia) and serves as a neurology consultant for the World Health Organization. Her educational background includes an MD from Tufts University School of Medicine (2008), internship at Johns Hopkins Hospital's Osler Medical Service, neurology residency at Harvard's Brigham & Women's Hospital (where she served as chief resident), and fellowship in neuroinfectious disease/neuroimmunology at Johns Hopkins Hospital. She is additionally pursuing a Master of Science in clinical trials at the London School of Tropical Medicine and Hygiene. Dr. Thakur's research program focuses on improving detection and management of neuroinfectious diseases in hospital settings, with particular emphasis on vulnerable populations including HIV-positive individuals and immigrants. Her work integrates clinical, translational, and implementation science approaches to address cerebral malaria, tuberculous meningitis, Zika-related complications, and SARS-CoV-2 neurological outcomes. Current projects investigate novel diagnostics for infectious meningoencephalitis, risk factors for neuroinvasive infections, and therapeutic strategies for viral encephalitis. Analysis of her 15 most recent publications reveals consistent focus on neuroinfectious disease epidemiology (particularly in resource-limited settings), diagnostic challenges in immunocompromised patients, and global health implementation strategies. Her work prominently features Zika virus complications, tuberculous meningitis management, and CNS infections in travelers, reflecting her dual expertise in tropical medicine and neuroimmunology. Scientific recognition includes: Lewis P. Rowland Teaching Award (Columbia University, 2016) CDC Nakona Citation Award (2014) Dr. Thakur directs the NIH NINDS K23-funded study on pathogen identification in neurological infections (2018-2023) and leads Columbia's post-doctoral neuroinfectious disease fellowship for physician-scientists from low/middle-income countries. Her research program receives support from the NIH, World Federation of Neurology, and American Academy of Neurology, with implementation studies conducted in collaboration with WHO, PAHO, and CDC. The Thakur Laboratory at Columbia's Neurological Institute coordinates international research networks across Malawi, Vietnam, Bangladesh, Uganda, and the Dominican Republic. Her team conducts clinical trials on antimicrobial dosing, develops diagnostic algorithms for resource-limited settings, and implements training programs to build neuroinfectious disease capacity in underserved regions, with current emphasis on SARS-CoV-2 neurological sequelae and tropical disease management.

• Neuroinfectious Diseases
• Neuroimmunology
• Global Health
• +6 more

Dr. Tanya N Turan is a tenured Professor of Neurology at the Medical University of South Carolina (MUSC), serving as Vice-Chair of Neurology Faculty Affairs. She is a director of the NIH-StrokeNet Regional Coordinating Center "Southeast Collaborative Alliance for Stroke Trials (SE-CoAST)" and actively oversees multi-center clinical trials including SAMMPRIS, CREST 2, and CAPTIVA. Research Interests: Management of vascular risk factors in stroke Intracranial atherosclerosis Secondary stroke prevention Medical imaging techniques for plaque analysis Hypertensive disorders in pregnancy Hemodynamic assessment in cerebrovascular disease Clinical Trials & Grants: NIH-funded SAMMPRIS (Stenting vs. Aggressive Medical Management) CREST 2 (Carotid Revascularization Endarterectomy/Stenting) CAPTIVA (Anticoagulation vs. Antiplatelet Therapies) National StrokeNet infrastructure leadership Publication Trends: Her recent work focuses on intracranial atherosclerosis, vascular risk factors, and hemodynamic effects in stroke. Articles emphasize clinical trials, imaging biomarkers, and long-term outcomes in cerebrovascular disease.

• Management of Vascular Risk Factors in Stroke
• Intracranial Atherosclerosis
• Secondary Stroke Prevention
• +3 more

Katsuhito Yasuno is a Research Scientist in the Department of Neurosurgery at Yale School of Medicine. He works within the Gunel Lab, focusing on neurogenetic research related to brain disorders, vascular conditions, and tumors. His work involves genomic analyses and molecular studies to understand the genetic basis of various neurological conditions. Education: Postdoctoral Fellow, Japan Science and Technology Corporation (2008) Postdoctoral Fellow, Japan Biological Informatics Consortium (2006) Postdoctoral Fellow, Tokai University School of Medicine (2004) PhD in Theoretical Physics, Tokyo Institute of Technology (2002) MS in Theoretical Physics, Tokyo Institute of Technology (1999) BS in Physics, Tokyo Metropolitan University (1997) Dr. Yasuno's research spans multiple areas of neurogenetics and molecular neuroscience. His primary interests include epidemiologic factors and methods related to brain tumors (particularly glioblastoma and meningioma), intracranial aneurysms, nervous system diseases and malformations, and vascular diseases. His physics background contributes to sophisticated analytical approaches in genetic research. His publication record shows consistent contributions to understanding the genetic mechanisms underlying neurological disorders, with recent work focusing on meningioma genetics, brain malformations, and vascular disorders. The research demonstrates a progression from basic genetic discovery to translational applications, with particular emphasis on molecular pathways that could serve as therapeutic targets. Dr. Yasuno collaborates extensively with leading researchers in the field, most notably with Dr. Murat Günel (28 common publications) and Dr. Kaya Bilguvar (34 common publications). His work involves both computational analysis and laboratory validation of genetic findings. As part of the Gunel Lab, Dr. Yasuno contributes to the lab's three major research interests: developmental neurogenetic disorders, neurovascular disorders, and brain tumor biology. The lab utilizes advanced genomics techniques and bioinformatic analysis for gene discovery followed by functional studies.

• Epidemiologic Factors
• Epidemiologic Methods
• Glioblastoma
• +7 more

Dr. Soo J. Rhee is a Clinical Assistant Professor of Surgery in the Department of Surgery at Weill Cornell Medical College, Cornell University, and an Assistant Attending Surgeon in the Division of Vascular and Endovascular Surgery at NewYork-Presbyterian/Weill Cornell Medical Center. Board-certified in vascular and general surgery, she co-directs the Comprehensive Vein Program specializing in venous disorder treatments. Her educational background includes: B.A. from Princeton University (1996), graduating cum laude M.D. from New York University School of Medicine (2000) Dr. Rhee's research focuses on vascular interventions with expertise in minimally invasive varicose vein treatments (endovenous laser, radiofrequency, mechanochemical ablation) and spider vein sclerotherapy. She clinically manages deep vein thrombosis, venous ulcers, and pelvic vein disorders through the Comprehensive Vein Program. Her publication record emphasizes gender-specific outcomes in peripheral artery disease, carotid stenting safety profiles, and lesion complexity impacts on intervention success, demonstrating consistent contributions to evidence-based vascular surgery practices. Key recognitions include: W.L Gore research grant for basic science (2007) Third Prize at Montefiore Young Investigators' Symposium (2003) Third Prize in Resident Presentation Forum at New York Society of Colon and Rectal Surgeons (2003) Cum Laude Honors from Princeton University (1996) As co-director of the Comprehensive Vein Program, Dr. Rhee leads clinical innovation in venous disorder management while maintaining active surgical practice and research. Her work bridges translational research with direct patient care in vascular medicine. The Comprehensive Vein Program under her co-direction integrates advanced imaging and minimally invasive techniques to treat complex venous conditions from varicose veins to chronic venous insufficiency, serving as a regional referral center for venous disorders.

• Vascular Surgery
• Endovascular Surgery
• Vein Disorders
• +3 more

George E. Vates, MD, PhD, is a Professor in the Department of Neurosurgery and the Department of Medicine (Endocrine/Metabolism) at the University of Rochester Medical Center. He serves as neurosurgeon co-director of the University of Rochester Multidisciplinary Neuroendocrinology Clinic and is a key member of the University of Rochester Medical Faculty Group (URMFG), which comprises over 900 providers across 19 departments. Dr. Vates specializes in pituitary tumor surgery, cerebrovascular disorders, and skull base procedures, having performed over 120 transsphenoidal pituitary surgeries. Dr. Vates completed his academic training with exceptional distinction: Duke University: Bachelor's degree, summa cum laude (1988, Phi Beta Kappa) Rockefeller University: PhD in Neuroscience Weill Medical College of Cornell University: MD (1997, Alpha Omega Alpha) University of California, San Francisco: Neurosurgery Residency (1998-2003) Brigham and Women's Hospital, Harvard Medical School: Cerebrovascular/Skull Base Fellowship (2003-2004) His research focuses on pituitary tumor biology, neuroendocrinology, and surgical innovation. He established the Multidisciplinary Neuroendocrinology Clinic as a regional referral center for complex pituitary cases, integrating neurosurgical and endocrinological expertise. Current work emphasizes neuroprotective mechanisms in pituitary adenomas, surgical simulation technology, and optimizing outcomes for elderly glioma patients. Analysis of his 15 most recent publications reveals evolving research trajectories: contemporary studies (2019-2022) concentrate on pituitary tumor management, surgical simulation, and neurosurgical education, while earlier work (2002-2009) explored cerebrovascular anomalies, neural pathway mapping, and vascular malformations. Persistent themes include surgical technique refinement, tumor biology, and clinician training. Dr. Vates' scientific contributions have been recognized through: Phi Beta Kappa (1988) and Alpha Omega Alpha (1991) academic honors Neurosurgery Research and Education Foundation Fellowship (2006) Anspach Award for Cerebral Ischemia Research (2007) AANS Leadership Scholarship and Cone Pevehouse Award (2009) Ongoing service as St. Michael's Hospital Animal Care Committee reviewer As an educator, he mentors neurosurgery residents through clinical supervision and curriculum development, notably publishing on palliative care communication training. His research initiatives, including the 3D-printed cervical laminectomy simulator, demonstrate commitment to advancing surgical education. Current grants focus on neuroprotective strategies in pituitary tumors and resident training methodologies. Dr. Vates co-directs the Multidisciplinary Neuroendocrinology Clinic with endocrinologist Dr. Calvi, fostering collaboration between neurosurgery, endocrinology, and oncology. His clinical team manages complex pituitary cases across Rochester and Hornell campuses, while his research group develops surgical innovations and investigates tumor microenvironment interactions to improve patient outcomes.

• Neurosurgery
• Pituitary Tumors
• Neuroendocrinology
• +3 more

Mehmet S. Ozcan, MD is an Associate Professor of Anesthesiology at Yale School of Medicine and Section Chief of Neuroanesthesia. He specializes in neurosurgical and critical care anesthesia, focusing on cerebrovascular diseases, intracranial tumors, and intraoperative neurophysiologic monitoring. His roles include Co-Chief of the Division of Adult Multispecialty Anesthesia. Dr. Ozcan completed medical training at Istanbul University Cerrahpasa School of Medicine (1996), followed by residency and fellowships in anesthesiology and critical care at the University of Florida (2003–2005). He previously practiced at the University of Illinois Chicago and University of Oklahoma before joining Yale. Research interests include ethical considerations in neurocritical care, cerebrovascular management, and neuroanesthesia techniques. He has published extensively in peer-reviewed journals, with recent work focusing on medical device transparency, entropy analysis in anesthesia, and lipid emulsion therapies. Professional activities include serving on the Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Scientific Affairs Committee and editorial roles for journals like Anesthesia and Analgesia and Journal of Neurosurgical Anesthesia .

• Neuroanesthesia
• Neurocritical Care
• Cerebrovascular Diseases
• +3 more

Karol Budohoski, MD, PhD, FRCS, is an Assistant Professor in the Department of Neurosurgery at the University of Utah , with additional Adjunct Assistant Professor status in Radiology & Imaging Sciences. He specializes in cerebrovascular , endovascular , and skull base neurosurgery , treating complex pathologies like brain aneurysms, arteriovenous malformations, and skull base tumors. Education: PhD in Neurosurgery (University of Cambridge), MD (Medical University of Warsaw), Clinical Fellowships at University of Utah and UCSF His academic focus on subarachnoid hemorrhage pathophysiology and cerebral vasospasm has led to innovations in brain monitoring tools. Recent publications (2023-2025) span neurovascular surgery , stroke interventions , global neurosurgery , and cerebral autoregulation studies. He practices at the Clinical Neurosciences Center in Salt Lake City, Utah, with a patient rating of 4.9/5 (125 reviews), praised for clarity, attentiveness, and technical expertise.

• Cerebrovascular Surgery
• Endovascular Neurosurgery
• Skull Base Surgery
• +6 more

Rong Xu is a Professor of Biomedical Informatics at Case Western Reserve University School of Medicine, where she also serves as Director of the Center for AI in Drug Discovery. She is a member of the Cancer Genomics and Epigenomics Program at the Case Comprehensive Cancer Center. Dr. Xu's research focuses on developing innovative computational approaches including artificial intelligence, natural language processing, data mining, machine learning, and knowledge representation to advance biomedical discovery. Her work spans both computer science and biomedical science domains. Her computer science research interests include Artificial Intelligence, Natural Language Processing, Machine Learning, Deep Learning, Systems Biology, Data Mining, Graph Theory, and Ontology. Her biomedical science interests encompass Drug Discovery, Drug Repositioning, Disease Gene Discovery, Gene-Environment Interactions, Human Gut Microbiome, Drug Target Discovery, Drug Toxicity Prediction, Cancer Drug Toxicity, Drug Addiction, and Neuroscience Informatics. Dr. Xu's recent publications demonstrate a strong focus on applying AI and computational methods to drug discovery, particularly for neurological conditions, diabetes-related complications, and substance use disorders. Her work prominently examines the effects of GLP-1 receptor agonists like semaglutide on various health outcomes, including Alzheimer's disease, opioid use disorder, and cancer. Fellow of American College of Medical Informatics (FACMI) 2020 American College of Medical Informatics Research Scholar 2016 American Cancer Society New Investigator Award 2015 American Medical Informatics Association AACR INNOVATOR Award 2015 Landon Foundation Director's Innovator Award 2014 National Institutes of Health Siebel Scholar 2004 Dr. Xu directs the Center for AI in Drug Discovery and has received significant grant funding for her research, including a $1.4 million grant from NIDA for developing AI technologies to identify potential medications for cocaine use disorder. Her work bridges computational science with clinical applications, focusing on translating AI discoveries into practical healthcare solutions.

• Artificial Intelligence
• Natural Language Processing
• Machine Learning
• +18 more

Cam Ha Tran is an Assistant Professor in the Department of Physiology and Cell Biology at the University of Nevada, Reno, affiliated with the Institute of Neuroscience. Her research focuses on neurovascular unit interactions, particularly how blood flow regulation impacts brain function under health and disease conditions such as stroke and dementia. She employs advanced techniques like two-photon imaging, optogenetics, and electrophysiology to study astrocyte-endothelial communication and vascular reactivity. Education: PhD in Cardiovascular and Respiratory Sciences from the Cumming School of Medicine, University of Calgary (Canada); Master of Biomedical Technology and Bachelor of Science from the University of Alberta (Canada). Research emphasizes understanding how astrocytes and endothelial cells coordinate to maintain cerebral blood flow, with implications for neurological disorders. Her recent work explores TRPA1 channels in neurovascular coupling, astrocyte dysfunction in Alzheimer’s, and seizure-induced vascular changes. Techniques include in vivo imaging and chemogenetic approaches to dissect cellular mechanisms. Key contributions include uncovering astrocyte roles in functional hyperemia and identifying therapeutic targets for cerebrovascular diseases. Her lab’s findings bridge basic science and clinical applications, aiming to improve diagnostics and treatments for stroke and neurodegenerative conditions.

• Neuroscience
• Cardiovascular Physiology
• Neurovascular Coupling
• +4 more

Thomas Longden is an Associate Professor in the Department of Physiology at the University of Maryland School of Medicine. He leads a research group focused on neurovascular interactions in health and disease, with particular emphasis on understanding how blood flows through the brain under normal conditions and how this process is disrupted in diseases like Alzheimer's. Dr. Longden received his B.Sc (Hons) and Ph.D. in Pharmacology from the University of Manchester in the UK (2006 and 2010), followed by postdoctoral training at the University of Vermont under Professor Mark Nelson (2011-2015). He was promoted to Assistant Professor at Vermont in 2015 before joining the University of Maryland in February 2019. His research focuses on the control of blood flow in the brain, particularly the mechanisms of neurovascular coupling where neuronal activity triggers changes in blood flow. His lab has made significant discoveries including identifying the brain's capillary network as a 'sensory web' that translates neural activity into vasodilatory electrical signals, and demonstrating how pericytes function as metabolic sentinels that control blood flow through KATP channel-dependent mechanisms. Analysis of Dr. Longden's recent publications reveals a strong focus on pericyte function in neurovascular coupling, electrical signaling in the capillary network, and how these mechanisms are disrupted in Alzheimer's disease and other dementias. His work increasingly incorporates advanced imaging techniques, computational approaches, and innovative tools to study vascular plasticity. 2023: Fellow of the American Physiological Society Cardiovascular Section 2020: NIH Director's New Innovator Award 2017: American Heart Association Scientist Development Grant Multiple travel awards and postdoctoral fellowships Dr. Longden currently mentors several graduate students and postdoctoral fellows in the Longden Lab, which is supported by multiple NIH grants including an NINDS New Innovator Award and an NIA R01 grant. His lab develops and employs advanced techniques including multiphoton microscopy, electrophysiology, optogenetics, and molecular biology to study vascular cells in the brain. The lab is particularly focused on understanding vascular signaling plasticity and how pericytes control brain blood flow in health and Alzheimer's disease.

• Brain blood flow
• Neurovascular coupling
• Functional hyperemia
• +12 more